Many causes of incidental focal uptake on raw data images using myocardial perfusion imaging, including malignant diseases, metastatic processes, benign pathologies, and physiological conditions, have been reported in the literature. However, iatrogenic 99m Tc sestamibi emboli have not yet been reported. Herein, we demonstrated iatrogenic 99m Tc sestamibi embolization on consecutive rest and stressed myocardial perfusion images at different locations.
A
53-year-old male patient with hypertension and diabetes had a 15-day history of chest pain and was referred for myocardial perfusion scintigraphy. According to our department protocol, 1-day rest and stress myocardial integrated single-photon emission computed tomography/computed tomography (SPECT/CT) images were acquired. Rest SPECT/CT images obtained 60 min after injection of 10.7 mCi (395.9 MBq) of 99m Tc sestamibi revealed a normal myocardial perfusion with a focal uptake at the left hemithorax [ Figure 1a ]. This uptake was paired with focal 99m Tc-sestamibi accumulation in the anterior segment of the left upper lobe on SPECT/CT images with no pathologic pulmonary findings in the corresponding low-dose CT images [ Figure 1b ]. After rest imaging, the patient underwent a standard adenosine stress test. Subsequently, 140 μg/kg/min of adenosine infusion was administered over 6 min, and 31.1 mCi (1150.7 MBq) of 99m Tc-sestamibi was injected at the 3 rd min. Stress SPECT/CT myocardial perfusion images acquired 30 min after the pharmacological stress test revealed no sign of hypoperfusion or perfusion defects similar to those in the rest images. However, a focal 99m Tc-sestamibi uptake was observed at the right hemithorax on stress raw data images, and the focal activity accumulation in the left lung, which was detected on the rest images, disappeared [ Figure 1c ]. Stress SPECT/CT images demonstrated focal increased uptake of 99m Tc-sestamibi in the lateral segment of the right middle lobe without any pulmonary pathology on the reciprocal low-dose CT images [ Figure 1d ]. These aforementioned incidental focal 99m Tc-sestamibi accumulations in both lungs were evaluated as iatrogenic 99m Tc-sestamibi embolism due to the absence of accompanying pulmonary anomalies in the corresponding low-dose CT images and the disappearance and appearance of focal 99m Tc-sestamibi uptake on the consecutive rest and stress images. Information collected from raw data images is very important for detecting extracardiac findings using myocardial perfusion scintigraphy. Although many causes of incidental focal uptake on raw data images in myocardial perfusion imaging, including malignant diseases, metastatic processes, benign pathologies, and physiological conditions, have been reported in the literature, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] to the best of our knowledge, this report is the first to demonstrate iatrogenic 99m Tc-sestamibi embolization on rest and stress myocardial perfusion images at different locations. In our case, SPECT/CT helped to avoid additional diagnostic tests and radiation exposure
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and provided psychological comfort to the patient by identifying the false-positive result. For this reason, apart from its significant role in reducing attenuation artifacts and improving image quality, SPECT/CT may alter the approach for patients with extracardiac findings detected using myocardial perfusion imaging.
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